Chasity Parsons
Family · Lumberton, TXNPI 1518422948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $780, 2.4 times the $330 reported in 2021.
Across 78 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$335
- SK Life Science, Inc.$180
- Acadia Pharmaceuticals Inc$162
- Johnson & Johnson$142
- Lundbeck LLC$111
- Lilly USA, LLC$106
- plus $486 from 16 others
What the payments were for
- Food & beverage$1,522100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $335 |
| SK Life Science, Inc. | 7 | $180 |
| Acadia Pharmaceuticals Inc | 3 | $162 |
| Johnson & Johnson | 8 | $142 |
| Lundbeck LLC | 6 | $111 |
| Lilly USA, LLC | 5 | $106 |
| Amarin Pharma, Inc. | 5 | $85 |
| Novo Nordisk | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Pfizer | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Bayer | 2 | $34 |
| GSK | 1 | $23 |
| Sanofi | 1 | $23 |
| Mylan Specialty L.p. | 1 | $21 |
| Abbott | 1 | $20 |
| AstraZeneca | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Advanced Respiratory, Inc | 1 | $14 |
| Amgen | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,522 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 51 | $1,541 |
| Memantine Hcl | 36 | $1,095 |
| Rivastigmine | 19 | $1,000 |
| Divalproex Sodium | 74 | $968 |
| Oxcarbazepine | 25 | $939 |
| Buspirone Hcl | 92 | $908 |
| Donepezil Hcl | 75 | $652 |
| Valproic AcidValproic Acid (As Sodium Salt) | 11 | $433 |
| Sertraline Hcl | 44 | $376 |
| Zonisamide | 20 | $295 |
| Trazodone Hcl | 28 | $248 |
| Mirtazapine | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other family in Lumberton
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.